Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene Technology Appointed Agilent Certified Service Provider

NEW YORK (GenomeWeb News) – Agilent Technologies has appointed Oxford Gene Technology as a certified service provider for its microarray products in Europe, the firms announced today.
 
Oxford, UK-based OGT said it gained certification after completing "several successful projects," such as transcription profiling of sequenced microorganisms and array-based comparative genomic hybridization experiments.
 
In early 2007, the firms inked an agreement that gave OGT access to Agilent’s microarray platform and made Agilent an OEM supplier of OGT-designed microarrays.
 
OGT was founded in 1995 to protect the patent estate of microarray inventor Sir Edwin Southern. In 2004, it began developing customized arrays for researchers around the world.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.